Opyl snares ex-Cochlear executive as medtech’s platforms approach launch

Clinical trial recruitment and design solution company Opyl is picking up momentum with the appointment of former Cochlear executive Mark Ziirsen as a non-executive director.

“The company’s at a very exciting stage, with the way it’s managed to turn itself around and focus on digital health,” executive Mark Ziirsen said. “Digital health is a strong thematic.”

This is only an excerpt. This piece was originally was written by Stockhead and can be found here.